🟢 Femasys is trading 5.6% up in pre-market as catalyst remains unclear

Femasys is trading $2.69 (+5.60%) in pre-market, with the catalyst remaining unclear.

• No new company-specific announcement dated September 18, 2026 was identified.
• Recent coverage includes Femasys’ September 15 adoption announcement involving Minnesota Women’s Care.
• The FDA modular PMA milestone was announced August 19; broader indexes are mixed, and neither clearly explains the move.